CymaBay Therapeutics
Developing therapies for liver and other chronic diseases with high unmet medical need. Learn more
Launch date
Employees
Market cap
CAD5.1b
Enterprise valuation
CAD4.7b (Public information from Mar 2024)
Share price
$32.48 CBAY
Hayward California (HQ)
Authorizing premium user...